The drug pricing challenge -- Payers -- Fundamentals of pricing -- Reference based pricing -- Health outcomes and health economics -- Features, benefits, value and price -- Pricing and drug development -- Payer segmentation -- Key situation factors : the podium approach -- The best price framework to pricing and market access -- Payer value story -- Developing a global pricing strategy -- Public policy and ethical considerations -- Oncology and orphan drugs -- Payer and pricing research -- Corporate market access and pricing function -- Market access and pricing negotiations -- Risk sharing and managed entry agreements -- United states -- Canada -- France -- Germany -- Italy -- Spain -- UK -- Japan -- Australia -- Brazil -- China -- India -- South Korea.